Impact BioMedical Inc. (IBO)
NYSEAMERICAN: IBO · Real-Time Price · USD
5.14
+0.37 (7.76%)
Nov 13, 2026, 4:00 PM EST - Market closed
Impact BioMedical Employees
Impact BioMedical had 2 employees as of December 31, 2025. The number of employees did not change compared to the previous year. That makes Impact BioMedical the 43,468th largest employer in the world and 6,986th in the United States.
Employees
2
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
$19,000
Profits / Employee
$807,000
Market Cap
43.91M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 2 | 0 | - |
| Dec 31, 2024 | 2 | 1 | 100.00% |
| Dec 31, 2023 | 1 | -1 | -50.00% |
| Dec 31, 2022 | 2 | 0 | - |
| Dec 31, 2021 | 2 | 0 | - |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| MindWalk Holdings | 77 |
| Connect Biopharma Holdings | 64 |
| Pliant Therapeutics | 49 |
| Biomea Fusion | 37 |
| Elicio Therapeutics | 33 |
| Oncolytics Biotech | 29 |
| iBio, Inc. | 23 |
| Gain Therapeutics | 21 |
IBO News
- 6 days ago - Impact BioMedical Quarterly report: Q3 2026 - Filings
- 19 days ago - Impact BioMedical Proxy statement: Proxy filing - Filings
- 7 weeks ago - Impact Biomedical Inc trading resumes - TheFly
- 7 weeks ago - Impact Biomedical Inc trading halted, volatility trading pause - TheFly
- 2 months ago - Impact Biomedical Inc Announces Filing of Form F-4 Registration Statement in Connection with Proposed Merger with Zoar Ltd. (f/k/a Dr. Ashley's Limited) - GlobeNewsWire
- 2 months ago - CORRECTED — Impact Biomedical Inc (NYSE: IBO) Announces 1 for 12.62 Reverse Stock Split to Pursue Completion of Merger with Zoar Limited (f/k/a Dr Ashleys Limited) - GlobeNewsWire
- 2 months ago - Impact BioMedical announces 1 for 12.62 reverse stock split - TheFly
- 2 months ago - Impact BioMedical Inc (NYSE American: IBO) Announces 1 for 12.62 Reverse Stock Split to Pursue Completion of Merger with Zoar Ltd. (previously Dr. Ashley's Ltd. - GlobeNewsWire